Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,371 Crohns Disease
clinical trials

Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
The Gastroenterology Group, P.C.
mi
from
Reston, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Apex Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Brigham and Women's Hospital - Crohn's and Colitis Center
mi
from
Chestnut Hill, MA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Peak Gastroenterology Associates
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Adirondack Medical Research Center
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Qway Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Vista Health Research
mi
from
Homestead, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kentucky Health Care
mi
from
Lexington, KY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
VA Northern California Health Care System
mi
from
Mather, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Associates of South Florida, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
LMG Research
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
TrialSpark
mi
from
New York, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
HMD Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Guardian Angel Health Svcs Inc
mi
from
Tampa, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Allergy, Asthma and Immunology Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Asclepes Research Centers
mi
from
Weeki Wachee, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of SWLA, LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Atlantic Health Specialists
mi
from
Galax, VA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research, San Pablo
mi
from
San Pablo, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Harvard Medical School - Beth Israel Deaconess Medical Center (BIDMC) - The Center for Vascular Biol
mi
from
Boston, MA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley View Internal Medicine
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Floridian Clinical Research LLC
mi
from
Hialeah, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
ABS Health, LLC
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Nola Research Works
mi
from
New Orleans, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Circuit Clinical
mi
from
Orchard Park, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatologist Specialists of Spokane
mi
from
Spokane, WA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Penn State University Milton S Hershey Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Gastroenterology institute
mi
from
Suffolk, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Avant Research Associates, LLC - Beaumont
mi
from
Beaumont, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Universal Axon Clinical Research, LLC
mi
from
Doral, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Research, LLC
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Internal Medicine Specialists
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Liverpool Hospital
mi
from
Liverpool,
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Innovation Research Institute, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facey Medical Foundation (Parent)
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Bayside Clinical Research
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Theia Clinical Research
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
San Antonio Gastroenterology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
New Hope Research Development
mi
from
West Covina, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Qway Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Southtowns Gastroenterology, PLLC
mi
from
Orchard Park, NY
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwell Health
mi
from
Lake Success, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Winchester Gastroenterology Associates
mi
from
Winchester, MA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Medical Professional Clinical Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Advanced Research, Inc
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Lomita Family Medical Group, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Gastroenterology Specialists, PC
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Renaissance Research Medical Group, INC
mi
from
Cape Coral, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastro Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
IL Gastroenterology Group
mi
from
Gurnee, IL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
Biopharma Informatic Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
East Coast Institute for Research LLC
mi
from
Saint Augustine, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Status: Enrolling, Phase III
Updated: 12/31/1969
San Antonio Gastroenterology Associates Clinical Trials (SAGACT PLLC)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Athens, GA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Caro, MI
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Fort Mill, SC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Tupelo, MS
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Vineland, NJ
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Waterbury, CT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Homestead, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Marlborough, MA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Mentor, OH
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Pasadena, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Plant City, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Towson, MD
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Neurology, Rheumatology Clinical Trial
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
North Georgia Rheumatology Group
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Neurology, Rheumatology Clinical Trial
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
SunValley Arthritis Center Ltd
mi
from
Peoria, AZ
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Neurology, Rheumatology Clinical Trial
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
West Virginia Research Institute
mi
from
South Charleston, WV
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hospital Italiano
mi
from
Buenos Aires,
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
UC Health Clinical Trials Office
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Innovative Clinical Research
mi
from
Greenville, SC
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine; Gastroenterology
mi
from
Houston, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Regenerate Clinical Trials
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Moore Clinical Trials, LLC
mi
from
Sherwood, AR
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Digestive Disease Consultants - Southlake
mi
from
Southlake, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Allied Gastrointestinal Associates, PA
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Virginia; Gastroenterology and Hepatology
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Clin. Rsrch Inst. of Michigan
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
GastroCare; Digestive Care Research
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Iowa Digestive Disease Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Gastroenterology Cnslts
mi
from
Glendora, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Long Island Clin Rsch Asc, LLP
mi
from
Great Neck, NY
Click here to add this to my saved trials
1 … 12 13 14 15 16 17 18 19 20 21 22 23 24